No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs1512734 |
chr12:85702371-85702372 |
Weak transcription Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs145599985 |
chr12:85702478-85702479 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs1398446 |
chr12:85702511-85702512 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs562827751 |
chr12:85702515-85702516 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs533364982 |
chr12:85702549-85702550 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs184404377 |
chr12:85702559-85702560 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs566992526 |
chr12:85702573-85702574 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs527475485 |
chr12:85702600-85702601 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs570130131 |
chr12:85702618-85702619 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs549135262 |
chr12:85702652-85702653 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs189516802 |
chr12:85702664-85702665 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs534653107 |
chr12:85702672-85702673 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs4761131 |
chr12:85702717-85702718 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs556042762 |
chr12:85702749-85702750 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs570908323 |
chr12:85702758-85702759 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs35286097 |
chr12:85702776-85702777 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs371344634 |
chr12:85702823-85702824 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs553569893 |
chr12:85702824-85702825 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs192972272 |
chr12:85702889-85702890 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs148510540 |
chr12:85702896-85702897 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs142747540 |
chr12:85702976-85702977 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs574291107 |
chr12:85702999-85703000 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs549167899 |
chr12:85703025-85703026 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs184348635 |
chr12:85703031-85703032 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs369050714 |
chr12:85703064-85703065 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs74111962 |
chr12:85703101-85703102 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs146592168 |
chr12:85703147-85703148 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs527752624 |
chr12:85703251-85703252 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs189630610 |
chr12:85703254-85703255 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs180912235 |
chr12:85703268-85703269 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs200584540 |
chr12:85703407-85703408 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs386377227 |
chr12:85703408-85703409 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs75588696 |
chr12:85703409-85703410 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs374734043 |
chr12:85703422-85703423 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs7313265 |
chr12:85703488-85703489 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs141295051 |
chr12:85703496-85703497 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs571240930 |
chr12:85703497-85703498 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs538224582 |
chr12:85703543-85703544 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs186292189 |
chr12:85703587-85703588 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs543261386 |
chr12:85703628-85703629 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs536302253 |
chr12:85703638-85703639 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs558410428 |
chr12:85703665-85703666 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs116353152 |
chr12:85703693-85703694 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs555463702 |
chr12:85703717-85703718 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs376546713 |
chr12:85703749-85703750 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs115746964 |
chr12:85703750-85703751 |
Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs189556366 |
chr12:85703867-85703868 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs573786019 |
chr12:85703868-85703869 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs578243465 |
chr12:85703877-85703878 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs140077518 |
chr12:85703984-85703985 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|